[Video Release] Introduction of BUS-DDS in TEDx Talk
We are pleased to announce that the following talk delivered at TEDxTeikyoU has been published on the TEDxTalks YouTube channel: “Theranostic bubbles & US deliver drugs | Kazuo Maruyama | TEDxTeikyoU” In this presentation, our President and CEO, Kazuo Maruyama, introduces our drug delivery technology, “BUS-DDS,” which utilizes ultrasound and bubbles. The talk provides an […]
Website Update and Publication of Policies
We are pleased to announce an update to our website. This update includes the publication of our Privacy Policy, Terms of Use, and Compliance Statememt, which clarify our approach to personal information management, intellectual property protection, and regulatory compliance. Privacy Policy: https://wellthera.tech/en/privacy-policy/ Terms of use: https://wellthera.tech/en/terms-of-use/ Compliance Statement: https://wellthera.tech/en/compliance-statement/ We will continue to […]
Notice of Director Appointments
We are pleased to announce that at our General Shareholders’ Meeting held on February 25, 2026, we amended our Articles of Incorporation to transition to a new management structure with one or more Representative Directors. Following this change, the following directors have been appointed: Representative Director (Newly Appointed) Makoto Shimasaki Director (Newly Appointed) Michael Paumen […]
Notice of Website Update
We are pleased to announce that our corporate website has been updated. This update includes a reorganization of information related to our business activities, along with partial revisions to the website structure and design for clarity. Please note that this update is intended solely for information organization and does not represent any new or modified […]
Notice of Capital Reduction
Wellthera Co., Ltd. announces that, effective 30 November 2025, the company has completed a reduction of its share capital as outlined below. Details of the Capital Reduction Share Capital After the Reduction JPY 30,000,000 Effective Date 30 November 2025 Purpose of the Capital Reduction This capital reduction was carried out as part of our […]
Change in the Board of Directors
On October 17, 2025, Mr. Hodaka Nakanishi resigned from his position as a Director of the Company. Accordingly, at the extraordinary general meeting of shareholders held on October 28, 2025, Ms. Tsubame Nishikai was newly appointed and assumed the position of Director. Outgoing Director: Hodaka Nakanishi Newly Appointed Director: Tsubame Nishikai We sincerely […]
Meet Wellthera at BioJapan 2025
Discover our innovative BUS-DDS platform and explore potential partnering opportunities at BioJapan 2025, held from October 8 (Wed) to October 10 (Fri) at Pacifico Yokohama. https://jcd-expo.jp/en/visit.html Booth No.: D-55 Actively participating in the Partnering Program We look forward to welcoming you to our booth! Contact us WellThera Co., Ltd. Head of Development […]
Executive Appointment Notice
Wellthera Co., Ltd. announces the following changes in its executive leadership, as approved at the Extraordinary General Meeting of Shareholders held on July 29, 2025. Effective July 29, 2025: • Retiring Representative Director: Mr. Taizō Imai (for health reasons) • New Representative Director: Mr. Kazuo Maruyama • Newly Appointed Director: Mr. Makoto Shimazaki We […]